Relevant of neutralizing antibody during SARS-CoV-2 infection and their therapeutic usage

被引：5
|
作者：
Gupta, Sneh Lata [1 ]
Jaiswal, Rishi K. [2 ]
机构：
[1] Natl Inst Immunol, New Delhi 110067, India
[2] Loyola Univ Chicago, Cardinal Bernardin Canc Ctr, Stritch Sch Med, Dept Canc Biol, Maywood, IL 60153 USA
来源：
MOLECULAR BIOLOGY REPORTS | 2022年 / 49卷 / 10期
关键词：
SARS-CoV-2; Neutralizing antibodies; Receptor binding domain (RBD); Omicron variant; Delta variant;
D O I：
10.1007/s11033-022-07493-z
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：10137 / 10140
页数：4
相关论文
共 50 条
  • [21] Therapeutic activity of an inhaled potent SARS-CoV-2 neutralizing human monoclonal antibody in hamsters
    Piepenbrink, Michael S.
    Park, Jun-Gyu
    Oladunni, Fatai S.
    Deshpande, Ashlesha
    Basu, Madhubanti
    Sarkar, Sanghita
    Loos, Andreas
    Woo, Jennifer
    Lovalenti, Phillip
    Sloan, Derek
    Ye, Chengjin
    Chiem, Kevin
    Bates, Christopher W.
    Burch, Reuben E.
    Erdmann, Nathaniel B.
    Goepfert, Paul A.
    Truong, Vu L.
    Walter, Mark R.
    Martinez-Sobrido, Luis
    Kobie, James J.
    CELL REPORTS MEDICINE, 2021, 2 (03)
  • [22] Therapeutic approaches for SARS-CoV-2 infection
    Gupta, Ankur
    Pradhan, Anish
    Maurya, Vimal K.
    Kumar, Swatantra
    Theengh, Angila
    Puri, Bipin
    Saxena, Shailendra K.
    METHODS, 2021, 195 : 29 - 43
  • [23] Characterization of neutralizing antibody with prophylactic and therapeutic efficacy against SARS-CoV-2 in rhesus monkeys
    Shuang Wang
    Yun Peng
    Rongjuan Wang
    Shasha Jiao
    Min Wang
    Weijin Huang
    Chao Shan
    Wen Jiang
    Zepeng Li
    Chunying Gu
    Ben Chen
    Xue Hu
    Yanfeng Yao
    Juan Min
    Huajun Zhang
    Ying Chen
    Ge Gao
    Peipei Tang
    Gang Li
    An Wang
    Lan Wang
    Jinchao Zhang
    Shuo Chen
    Xun Gui
    Zhiming Yuan
    Datao Liu
    Nature Communications, 11
  • [24] Diverse immunoglobulin gene usage and convergent epitope targeting in neutralizing antibody responses to SARS-CoV-2
    Zhou, Xiaojuan
    Ma, Fengge
    Xie, Jun
    Yuan, Meng
    Li, Yunqiao
    Shaabani, Namir
    Zhao, Fangzhu
    Huang, Deli
    Wu, Nicholas C.
    Lee, Chang-Chun D.
    Liu, Hejun
    Li, Jiali
    Chen, Zhonghui
    Hong, Yazhen
    Liu, Wen-Hsien
    Xiao, Nengming
    Burton, Dennis R.
    Tu, Haijian
    Li, Hang
    Chen, Xin
    Teijaro, John R.
    Wilson, Ian A.
    Xiao, Changchun
    Huang, Zhe
    CELL REPORTS, 2021, 35 (06):
  • [25] SARS-CoV-2 infection elicits a rapid neutralizing antibody response that correlates with disease severity
    Trinite, Benjamin
    Tarres-Freixas, Ferran
    Rodon, Jordi
    Pradenas, Edwards
    Urrea, Victor
    Marfl, Silvia
    Rodriguez de la Concepcion, Maria Luisa
    Avila-Nieto, Carlos
    Aguilar-Gurrieri, Carmen
    Barajas, Ana
    Ortiz, Raquel
    Paredes, Roger
    Mateu, Lourdes
    Valencia, Alfonso
    Guallar, Victor
    Ruiz, Lidia
    Grau, Eulalia
    Massanella, Marta
    Puig, Jordi
    Chamorro, Anna
    Izquierdo-Useros, Nuria
    Segales, Joaquim
    Clotet, Bonaventura
    Carrillo, Jorge
    Vergara-Alert, Julia
    Blanco, Julia
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [26] SARS-CoV-2 Epitopes following Infection and Vaccination Overlap Known Neutralizing Antibody Sites
    Yang, Li
    Liang, Te
    Pierson, Lane M.
    Wang, Hongye
    Fletcher, Jesse K.
    Wang, Shu
    Bao, Duran
    Zhang, Lili
    Huang, Zhen
    Zheng, Wenshu
    Zhang, Xiaomei
    Park, Heewon
    Li, Yuwen
    Robinson, James E.
    Feehan, Amy K.
    Lyon, Christopher J.
    Cao, Jing
    Morici, Lisa A.
    Li, Chenzhong
    Roy, Chad J.
    Yu, Xiaobo
    Hu, Tony
    RESEARCH, 2022, 2022
  • [27] Symptomatic and Asymptomatic SARS-CoV-2 Infection and Follow-up of Neutralizing Antibody Levels
    CUI Shu Juan
    ZHANG Yi
    GAO Wen Jing
    WANG Xiao Li
    YANG Peng
    WANG Quan Yi
    PANG Xing Huo
    ZENG Xiao Peng
    LI Li Ming
    Biomedical and Environmental Sciences, 2022, 35 (12) : 1100 - 1105
  • [28] Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection
    Reynolds, Catherine J.
    Swadling, Leo
    Gibbons, Joseph M.
    Pade, Corinna
    Jensen, Melanie P.
    Diniz, Mariana O.
    Schmidt, Nathalie M.
    Butler, David K.
    Amin, Oliver E.
    Bailey, Sasha N. L.
    Murray, Sam M.
    Pieper, Franziska P.
    Taylor, Stephen
    Jones, Jessica
    Jones, Meleri
    Lee, Wing-Yiu Jason
    Rosenheim, Joshua
    Chandran, Aneesh
    Joy, George
    Di Genova, Cecilia
    Temperton, Nigel
    Lambourne, Jonathan
    Cutino-Moguel, Teresa
    Andiapen, Mervyn
    Fontana, Marianna
    Smit, Angelique
    Semper, Amanda
    O'Brien, Ben
    Chain, Benjamin
    Brooks, Tim
    Manisty, Charlotte
    Treibel, Thomas
    Moon, James C.
    Noursadeghi, Mahdad
    Altmann, Daniel M.
    Maini, Mala K.
    McKnight, Aine
    Boyton, Rosemary J.
    SCIENCE IMMUNOLOGY, 2020, 5 (54)
  • [29] SARS-CoV-2 Epitopes following Infection and Vaccination Overlap Known Neutralizing Antibody Sites
    Yang, Li
    Liang, Te
    Pierson, Lane M.
    Wang, Hongye
    Fletcher, Jesse K.
    Wang, Shu
    Bao, Duran
    Zhang, Lili
    Huang, Zhen
    Zheng, Wenshu
    Zhang, Xiaomei
    Park, Heewon
    Li, Yuwen
    Robinson, James E.
    Feehan, Amy K.
    Lyon, Christopher J.
    Cao, Jing
    Morici, Lisa A.
    Li, Chenzhong
    Roy, Chad J.
    Yu, Xiaobo
    Hu, Tony
    Research, 2022, 2022
  • [30] Differential serological and neutralizing antibody dynamics after an infection by a single SARS-CoV-2 strain
    Billon-Denis, Emmanuelle
    Ferrier-Rembert, Audrey
    Garnier, Annabelle
    Cheutin, Laurence
    Vigne, Clarisse
    Tessier, Emilie
    Denis, Jessica
    Badaut, Cyril
    Rougeaux, Clemence
    Depeille Wuille, Anne
    Timera, Hawa
    Boutin, Laet itia
    Drouet, Isabelle
    Verguet, Noemie
    Nolent, Flora
    Gorge, Olivier
    Ferraris, Olivier
    Tournier, Jean-Nicolas
    INFECTION, 2021, 49 (04) : 781 - 783
12345